Effect of Inulin-type Fructans on Blood Lipid Profile and Glucose Level: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview

Journal Eur J Clin Nutr

Specialty Nutritional Sciences

Date 2016 Sep 15

PMID 27623982

Citations 58

Authors

F Liu

M Prabhakar

J Ju

H Long

H-W Zhou

Affiliations

Soon will be listed here.

Abstract

Background/objectives: This systematic review and meta-analysis was performed to assess the effects of inulin-type fructans (ITF) on human blood lipids and glucose homeostasis associated with metabolic abnormalities, including dyslipidemia, overweight or obesity, and type-2 diabetes mellitus (T2DM).

Subjects/methods: The MEDLINE, EMBASE and Cochrane Library databases were systematically searched for randomized controlled trials (RCTs) before January 2016. Human trials that investigated the effects of ITF supplementation on the lipid profile, fasting glucose and insulin were included using Review Manager 5.3.

Results: Twenty RCTs with 607 adult participants were included in this systematic review and meta-analysis. In the overall analysis, the supplementation of ITF reduced only the low density lipoprotein-cholesterol (LDL-c) (mean difference (MD): -0.15; 95% confidence interval (CI): -0.29, -0.02; P=0.03) without affecting the other endpoints. Within the T2DM subgroup analysis, ITF supplementation was positively associated with a decreased fasting insulin concentration (MD: -4.01; 95% CI: -5.92, -2.09; P<0.0001) and increased high density lipoprotein-cholesterol (HDL-c) (MD: 0.07; 95% CI: 0, 0.14; P=0.05). Moreover, a reduced fasting glucose tendency was identified only in the T2DM subgroup (MD: -0.42; 95% CI: -0.90, 0.06; P=0.09). There was a potential publication bias, and few trials were available for the T2DM subgroup analysis.

Conclusions: In summary, the use of ITF may have benefits for LDL-c reduction across all study populations, whereas HDL-c improvement and glucose control were demonstrated only in the T2DM subgroup. Thus, additional, well-powered, long-term, randomized clinical trials are required for a definitive conclusion. Overall, ITF supplementation may provide a novel direction for improving the lipid profile and glucose metabolism.

Citing Articles

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Ciobarca D, Catoi A, Gavrilas L, Banc R, Miere D, Filip L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006091 PMC: 11859434. DOI: 10.3390/ph18020279.

Inulin as a Biopolymer; Chemical Structure, Anticancer Effects, Nutraceutical Potential and Industrial Applications: A Comprehensive Review.

Karimi I, Ghowsi M, Mohammed L, Haidari Z, Nazari K, Schioth H Polymers (Basel). 2025; 17(3).

PMID: 39940613 PMC: 11819723. DOI: 10.3390/polym17030412.

Polysaccharides: The Sweet and Bitter Impacts on Cardiovascular Risk.

Kalisz G, Popiolek-Kalisz J Polymers (Basel). 2025; 17(3).

PMID: 39940607 PMC: 11820192. DOI: 10.3390/polym17030405.

A data-driven machine learning algorithm to predict the effectiveness of inulin intervention against type II diabetes.

Yang S, Weiskirchen R, Zheng W, Hu X, Zou A, Liu Z Front Nutr. 2025; 11():1520779.

PMID: 39839293 PMC: 11747270. DOI: 10.3389/fnut.2024.1520779.

Using Genetics to Assess the Role of Acetate in Ischemic Heart Disease, Diabetes, and Sex-Hormone-Related Cancers: A Mendelian Randomization Study.

Zhao J, Zhang J Nutrients. 2024; 16(21).

PMID: 39519507 PMC: 11547320. DOI: 10.3390/nu16213674.

References

Mithieux G, Gautier-Stein A . Intestinal glucose metabolism revisited. Diabetes Res Clin Pract. 2014; 105(3):295-301. DOI: 10.1016/j.diabres.2014.04.008. View

Parnell J, Reimer R . Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009; 89(6):1751-9. PMC: 3827013. DOI: 10.3945/ajcn.2009.27465. View

Cani P, Delzenne N . Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007; 10(6):729-34. DOI: 10.1097/MCO.0b013e3282efdebb. View

van Dokkum W, Wezendonk B, Srikumar T, van den Heuvel E . Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr. 1999; 53(1):1-7. DOI: 10.1038/sj.ejcn.1600668. View

Brighenti F . Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr. 2007; 137(11 Suppl):2552S-2556S. DOI: 10.1093/jn/137.11.2552S. View

Gibson G, Roberfroid M . Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125(6):1401-12. DOI: 10.1093/jn/125.6.1401. View

Delzenne N, Neyrinck A, Cani P . Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2011; 10 Suppl 1:S10. PMC: 3231917. DOI: 10.1186/1475-2859-10-S1-S10. View

Backhed F, Ding H, Wang T, Hooper L, Koh G, Nagy A . The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. PMC: 524219. DOI: 10.1073/pnas.0407076101. View

Larsen N, Vogensen F, van den Berg F, Nielsen D, Andreasen A, Pedersen B . Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010; 5(2):e9085. PMC: 2816710. DOI: 10.1371/journal.pone.0009085. View

10.

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490(7418):55-60. DOI: 10.1038/nature11450. View

11.

Sterne J, Sutton A, Ioannidis J, Terrin N, Jones D, Lau J . Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343:d4002. DOI: 10.1136/bmj.d4002. View

12.

Davidson M, Maki K . Effects of dietary inulin on serum lipids. J Nutr. 1999; 129(7 Suppl):1474S-7S. DOI: 10.1093/jn/129.7.1474S. View

13.

Genta S, Cabrera W, Habib N, Pons J, Carillo I, Grau A . Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr. 2009; 28(2):182-7. DOI: 10.1016/j.clnu.2009.01.013. View

14.

Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S . Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011; 108(19):8030-5. PMC: 3093469. DOI: 10.1073/pnas.1016088108. View

15.

Delzenne N, Daubioul C, Neyrinck A, Lasa M, Taper H . Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr. 2002; 87 Suppl 2:S255-9. DOI: 10.1079/BJNBJN/2002545. View

16.

Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G . Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464):541-6. DOI: 10.1038/nature12506. View

17.

Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S . Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol. 2005; 71(10):6150-8. PMC: 1265942. DOI: 10.1128/AEM.71.10.6150-6158.2005. View

18.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62(10):1006-12. DOI: 10.1016/j.jclinepi.2009.06.005. View

19.

Roberfroid M, Delzenne N . Dietary fructans. Annu Rev Nutr. 1998; 18:117-43. DOI: 10.1146/annurev.nutr.18.1.117. View

20.

Wu T, Yang Y, Zhang L, Han J . [Systematic review of the effects of inulin-type fructans on blood lipid profiles: a meta-analysis]. Wei Sheng Yan Jiu. 2010; 39(2):172-6. View